Defining optimal immunotherapies for type 1 diabetes

Saved in:
Bibliographic Details
Corporate Authors: Symposium on Defining Optimal Immunotherapies for Type 1 Diabetes London, England); Novartis Foundation.; Wiley InterScience (Online service)
Group Author: Bock, Gregory.; Goode, Jamie
Published:
Literature type: Electronic eBook
Language: English
Series: Novartis Foundation symposium ; 292
Subjects:
Online Access: http://onlinelibrary.wiley.com/book/10.1002/9780470697405
Item Description: Proceedings of the Novartis Foundation Symposium on Defining optimal immunotherapies for type 1 diabetes, held at The Novartis Foundation, London, 11-12 July 2007.
Editors: Gregory Bock and Jamie Goode.
Carrier Form: 1 online resource (ix, 212 pages) : illustrations (some color).
Bibliography: Includes bibliographical references and indexes.
ISBN: 9780470697405
0470697407
9780470697412
0470697415
Index Number: RC661
CLC: R587.105
Contents: Pancreatic pathology in type 1 diabetes in human / Alan K. Foulis -- The [beta] cell population in type 1 diabetes / Daniel Pipeleers, Peter In 't Veld, Miriam Pipeleers-Marichal and Frans Gorus -- Bone marrow expressing a diabetes resistance MHC class II allele : diabetes deviation by chronic immune stimulation / Peter Reifsnyder, William Schott, Darcy Pomerleau, Mark D. Lessard, Brian W. Soper and Edward H. Leiter -- Resuscitating adaptive Tregs with combination therapies? / Damien Bresson and Matthias von Herrath -- Cytotoxic T cell mechanisms of [beta] cell destruction in non-obese diabetic mice / Thomas W.H. Kay, Nadine L. Dudek, Kate Graham, Eugene Estella, Eveline Angstetra, Mark D. McKenzie, Jan Allison and Helen E. Thomas -- Type 1 diabetes : chronic progressive autoimmune disease / Li Zhang, Roberto Gianani, Maki Nakayama, Edwin Liu, Masakazu Kobayashi, Erin Baschal, Liping Yu, Sunanda Babu, Abby Dawson, Kelly Johnson, Mohamed Jahromi, Theresa Aly, Pamela Fain, Jennifer Barker, Marian Rewers and George S. Eisenbarth -- Current and past prevention and intervention trials in type 1 diabetes / Teodora Staeva -- CD8 and cytotoxic T cells in type 1 diabetes / Mark Peakman -- Genetic and therapeutic control of diabetogenic CD8 T cells / Pere Santamaria -- Towards a curative therapy in type 1 diabetes : remission of autoimmunity, maintenance and augmentation of [beta] cell mass / Frank Waldron-Lynch, Matthias von Herrath and Kevan C. Herold -- Immune markers of disease and therapeutic intervention in type 1 diabetes / Bart O. Roep -- Re-establishing immune tolerance in type 1 diabetes via regulatory T cells / Silvia Gregori, Manuela Battaglia and Maria-Grazia Roncarolo -- Translating mucosal antigen based prevention of autoimmune diabetes to human / Ezio Bonifacio, Anette Ziegler, Peter Achenbach, Jennifer Barker and George S. Eisenbarth.